Opendata, web and dolomites

REBOOT SIGNED

First-in-class implants for bone regeneration surgery after a bone, ligament or tendon injury

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 REBOOT project word cloud

Explore the words cloud of the REBOOT project. It provides you a very rough idea of what is the project "REBOOT" about.

revolutionary    too    manufacturing    international    market    multiplied    functional    regeneration    bioactive    industrial    injuries    community    sales    life       validated    surgery    operation    world    suffering    30    launch    ligaments    outcomes    musculoskeletal    instrument    made    fragile    regenerative    surgical    worldwide    reboot    class    noraker    follow    orthopaedic    healing    knee    action    ceramic    bioabsorbable    revision    capablity    2018    first    implants    days    mixed    adoption    formula    abnormal    billions    poor    weights    2015    15    patients    synthetic    imperfect    screw    cruciate    recreate    native    turnover    bones    develops    population    trauma    patented    disruptive    feasibility    msd    metallic    msds    inflammation    sme    20    ages    injury    million    ligament    marketed    disorders    shows    chronic    perspectives    full    re    spiral    100    biocomposite    pain    toward    rate    polymer    people    transition    enter    bioresorbable    break    leaving    tendon    quality    create    experiencing    materials    structure    bone    millions    glass   

Project "REBOOT" data sheet

The following table provides information about the project.

Coordinator
NORAKER 

Organization address
address: 11/13 AVENUE ALBERT EINSTEIN CENTRE SCIENTIFIQUE ET TECHNOLOGIQUE
city: VILLEURBANNE
postcode: 69100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 3˙545˙000 €
 EC max contribution 2˙481˙500 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NORAKER FR (VILLEURBANNE) coordinator 2˙481˙500.00

Map

 Project objective

NORAKER develops first-in-class implants for regenerative orthopaedic surgery to offer full healing to patients suffering from a bone, ligament or tendon injury. With project REBOOT, NORAKER will create the market of bone regeneration surgery. Each year in Europe, 1,6 million people require orthopaedic surgery after a bone, ligament or tendon injury, with many more cases expected as population ages. The current implants (made of metallic or bioresorbable materials) show imperfect healing outcomes, leaving millions of patients with fragile bones and poor quality of life (with 30% of inflammation, 20% of revision surgery and millions suffering from chronic pain and musculoskeletal disorders, MSDs). It weights billions of follow-up costs on the community. Enter NORAKER’s biocomposite surgical implants, made of bioactive glass – a revolutionary ceramic – mixed with a synthetic polymer, both bioabsorbable. This technology shows disruptive regeneration action: it can recreate up to 100% of the native-like functional bone structure with no inflammation, no abnormal pain, no MSD and a very low re-operation rate (4%). Today this patented technology is adapted to knee cruciate ligaments regeneration (with a world-first biocomposite screw marketed in 2015). In a SME Instrument Phase 1 project (2018), NORAKER has validated the feasibility of a new biocomposite formula with broader perspectives of regeneration for tendon, ligament and bone injuries. The Phase 2 project will do the industrial scale-up of this biocomposite and launch the industrial production of the first range of implants for the bone trauma market. Their adoption will support the transition toward regenerative orthopaedic surgery and break the spiral of pain and MSDs, which too many patients are experiencing these days. With this disruptive offer, NORAKER will become a scale-up operating worldwide, with a large manufacturing capablity, international sales and turnover multiplied by 15 in five years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REBOOT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REBOOT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COPI (2020)

Carbon Offset Plug-in

Read More  

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More